Cite
HARVARD Citation
Bonaventura, A. et al. (2017). Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor–Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer. International journal of gynecological cancer. 27 (5), pp. 900-906. [Online].